The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 142.40
Bid: 142.20
Ask: 142.80
Change: -1.80 (-1.25%)
Spread: 0.60 (0.422%)
Open: 143.80
High: 143.80
Low: 139.80
Prev. Close: 144.20
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre Stabilisation Notice

6 Feb 2024 10:59

RNS Number : 1946C
HSBC Bank plc
06 February 2024
 

6th February 2024

 

Kier Group plc

Pre Stabilisation Notice

HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

Kier Group plc

Guarantor (if any):

na

Aggregate nominal amount:

GBP 250,000,000

Description:

Fixed 5yr

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc, Natwest Markets, Lloyds Bank Corporate Markets, IMI - Intesa Sanpaolo

Stabilisation period expected to start on:

8th February 2024

Stabilisation period expected to end no later than:

15th March 2024

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAKZGGZGVVGDZM
Date   Source Headline
19th Oct 20224:17 pmRNSDirector/PDMR Shareholding
12th Oct 20223:59 pmRNSHolding(s) in Company
7th Oct 202211:51 amRNSAnnual Financial Report
3rd Oct 202210:23 amRNSTotal Voting Rights
21st Sep 20223:42 pmRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSResults for the year ended 30 June 2022
2nd Sep 202210:08 amRNSHolding(s) in Company
1st Sep 202210:21 amRNSTotal Voting Rights
22nd Aug 202210:11 amRNSDirector/PDMR Shareholding
1st Aug 202210:00 amRNSTotal Voting Rights
29th Jul 20224:05 pmRNSHolding(s) in Company
20th Jul 202212:00 pmRNSDirector/PDMR Shareholding
19th Jul 20227:00 amRNSTrading Update
6th Jul 20227:00 amRNSBoard Appointment
1st Jul 202210:16 amRNSTotal Voting Rights
1st Jul 202210:14 amRNSBlock listing Interim Review
28th Jun 20229:41 amRNSHolding(s) in Company
22nd Jun 20224:29 pmRNSHolding(s) in Company
21st Jun 202211:44 amRNSDirector/PDMR Shareholding
1st Jun 202210:36 amRNSTotal Voting Rights
24th May 20227:00 amRNSTrading Update and Capital Markets Event
20th May 20222:36 pmRNSDirector/PDMR Shareholding
3rd May 202210:30 amRNSTotal Voting Rights
29th Apr 20221:00 pmRNSDirector Declaration
19th Apr 20224:32 pmRNSDirector/PDMR Shareholding
1st Apr 202212:28 pmRNSTotal Voting Rights
21st Mar 20222:05 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSResults for the six months ended 31 December 2021
1st Mar 202212:07 pmRNSTotal Voting Rights
21st Feb 20223:08 pmRNSDirector/PDMR Shareholding
2nd Feb 20223:05 pmRNSHolding(s) in Company
1st Feb 202212:07 pmRNSTotal Voting Rights
20th Jan 202212:18 pmRNSDirector/PDMR Shareholding
20th Jan 20227:00 amRNSTrading Update
4th Jan 202212:05 pmRNSTotal Voting Rights
4th Jan 202212:00 pmRNSBlock listing Interim Review
20th Dec 20214:10 pmRNSDirector/PDMR Shareholding
1st Dec 20212:37 pmRNSTotal Voting Rights
22nd Nov 20213:14 pmRNSDirector/PDMR Shareholding
19th Nov 20212:32 pmRNSResult of AGM
15th Nov 20211:13 pmRNSHolding(s) in Company
1st Nov 20213:17 pmRNSDirector/PDMR Shareholding
1st Nov 20219:38 amRNSTotal Voting Rights
29th Oct 202112:59 pmRNSDirector/PDMR Shareholding
26th Oct 20211:00 pmRNSDirector/PDMR Shareholding
19th Oct 20213:47 pmRNSDirector/PDMR Shareholding
19th Oct 202110:00 amRNSHolding(s) in Company
15th Oct 202111:43 amRNSAnnual Financial Report
5th Oct 202111:04 amRNSDirector/PDMR Shareholding
30th Sep 20219:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.